Detalhe da pesquisa
1.
Exercise for the Prevention of Anthracycline-Induced Functional Disability and Cardiac Dysfunction: The BREXIT Study.
Circulation;
147(7): 532-545, 2023 02 14.
Artigo
em Inglês
| MEDLINE
| 2023
| ID: mdl-36342348
Mostrar mais
Texto completo
Documentos relacionados
2.
Protective effects of arbutin against doxorubicin-induced cardiac damage.
Mol Biol Rep;
51(1): 532, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE
| Abr 2024
| ID: mdl-38637360
3.
Approaches for reducing chemo/radiation-induced cardiotoxicity by nanoparticles.
Environ Res;
244: 117264, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE
| 2024
| ID: mdl-37776941
4.
Association between Statin Use and Chemotherapy-Induced Cardiotoxicity: A Meta-Analysis.
Medicina (Kaunas);
60(4)2024 Mar 31.
Artigo
em Inglês
| MEDLINE
| Abr 2024
| ID: mdl-38674227
5.
Advances in the application of nanotechnology in reducing cardiotoxicity induced by cancer chemotherapy.
Semin Cancer Biol;
86(Pt 2): 929-942, 2022 11.
Artigo
em Inglês
| MEDLINE
| 2022
| ID: mdl-34375726
6.
Cardiovascular Toxicity and Risk Mitigation with Lung Cancer Treatment.
Curr Oncol Rep;
25(5): 433-444, 2023 05.
Artigo
em Inglês
| MEDLINE
| Fev 2023
| ID: mdl-36811807
7.
Protective effect of vitamin B6 against doxorubicin-induced cardiotoxicity by modulating NHE1 expression.
J Biochem Mol Toxicol;
37(10): e23403, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| Set 2023
| ID: mdl-37701944
8.
Cardio-oncology for Pediatric and Adolescent/Young Adult Patients.
Curr Treat Options Oncol;
24(8): 1052-1070, 2023 08.
Artigo
em Inglês
| MEDLINE
| Jun 2023
| ID: mdl-37296365
9.
Critical appraisal of clinical guidelines for prevention and management of doxorubicin-induced cardiotoxicity.
J Oncol Pharm Pract;
29(3): 695-708, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| 2023
| ID: mdl-36567532
10.
Exploration of current pharmacy practice in cardio-oncology: Experiences & perspectives.
J Oncol Pharm Pract;
29(8): 1844-1852, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| 2023
| ID: mdl-36537037
11.
Protective effects of Panax ginseng against doxorubicin-induced cardiac toxicity in patients with non-metastatic breast cancer: A randomized, double-blind, placebo-controlled clinical trial.
J Oncol Pharm Pract;
29(6): 1306-1316, 2023 Sep.
Artigo
em Inglês
| MEDLINE
| 2023
| ID: mdl-35975564
12.
[2022 ESC guidelines on cardio-oncology : Understanding and treating cardiovascular side effects from cancer therapy]. / ESC-Leitlinie 2022 onkologische Kardiologie : Kardiovaskuläre Nebenwirkungen durch Krebstherapie verstehen und behandeln.
Herz;
48(1): 15-22, 2023 Feb.
Artigo
em Alemão
| MEDLINE
| 2023
| ID: mdl-36441175
13.
Selective inhibition of the NLRP3 inflammasome protects against acute ethanol-induced cardiotoxicity in an FBXL2-dependent manner.
Acta Biochim Biophys Sin (Shanghai);
55(12): 1972-1986, 2023 12 25.
Artigo
em Inglês
| MEDLINE
| Nov 2023
| ID: mdl-37994158
14.
Subcellular Effectors of Cocaine Cardiotoxicity: All Roads Lead to Mitochondria-A Systematic Review of the Literature.
Int J Mol Sci;
24(19)2023 Sep 25.
Artigo
em Inglês
| MEDLINE
| Out 2023
| ID: mdl-37833964
15.
Advancing The Cardiovascular Care in Cancer Patients on Chemotherapy.
Acta Med Indones;
55(4): 494-501, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| 2023
| ID: mdl-38213046
16.
Cardio-Oncology in Childhood: State of the Art.
Curr Oncol Rep;
24(12): 1765-1777, 2022 12.
Artigo
em Inglês
| MEDLINE
| Out 2022
| ID: mdl-36181610
17.
Global Longitudinal Strain Monitoring to Guide Cardioprotective Medications During Anthracycline Treatment.
Curr Oncol Rep;
24(6): 687-694, 2022 06.
Artigo
em Inglês
| MEDLINE
| Mar 2022
| ID: mdl-35239105
18.
Cardioprotection for Anti-HER2 Therapy: Considerations for Primary Prevention and Use in Mildly Reduced Left Ventricular Ejection Fraction.
Curr Oncol Rep;
24(8): 1063-1070, 2022 08.
Artigo
em Inglês
| MEDLINE
| Abr 2022
| ID: mdl-35362825
19.
Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment.
Curr Oncol Rep;
24(5): 543-553, 2022 05.
Artigo
em Inglês
| MEDLINE
| Fev 2022
| ID: mdl-35192118
20.
Effect of aerobic exercise on cardiotoxic outcomes in women with breast cancer undergoing anthracycline or trastuzumab treatment: a systematic review and meta-analysis.
Support Care Cancer;
30(12): 10323-10334, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| Nov 2022
| ID: mdl-36322246